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Abstract
Background: Osteoclast-mediated bone erosion is a central feature of rheumatoid arthritis (RA). Immune complexes,
present in a large percentage of patients, bind to Fcγ receptors (FcγRs), thereby modulating the activity
of immune cells. In this study, we investigated the contribution of FcγRs, and FcγRIV in particular, during
antigen-induced arthritis (AIA).
Methods: AIA was induced in knee joints of wild-type (WT), FcγRI,II,III−/−, and FcγRI,II,III,IV−/− mice. Bone
destruction, numbers of tartrate-resistant acid phosphatase-positive (TRAP+) osteoclasts, and inflammation
were evaluated using histology; expression of the macrophage marker F4/80, neutrophil marker NIMPR14,
and alarmin S100A8 was evaluated using immunohistochemistry. The percentage of osteoclast precursors
in the bone marrow was determined using flow cytometry. In vitro osteoclastogenesis was evaluated with
TRAP staining, and gene expression was assessed using real-time PCR.
Results: FcγRI,II,III,IV−/− mice showed decreased bone erosion compared with WT mice during AIA, whereas
both the humoral and cellular immune responses against methylated bovine serum albumin were not impaired in
FcγRI,II,III,IV−/− mice. The percentage of osteoclast precursors in the bone marrow of arthritic mice and their ability to
differentiate into osteoclasts in vitro were comparable between FcγRI,II,III,IV−/− and WT mice. In line with these
observations, numbers of TRAP+ osteoclasts on the bone surface during AIA were comparable between the
two groups. Inflammation, a process that strongly activates osteoclast activity, was reduced in FcγRI,II,III,IV−/−
mice, and of note, mainly decreased numbers of neutrophils were present in the joint. In contrast to FcγRI,II,III,IV−/−
mice, AIA induction in knee joints of FcγRI,II,III−/− mice resulted in increased bone erosion, inflammation, and numbers
of neutrophils, suggesting a crucial role for FcγRIV in the joint pathology by the recruitment of neutrophils. Finally,
significant correlations were found between bone erosion and the number of neutrophils present in the joint as well
as between bone erosion and the number of S100A8-positive cells, with S100A8 being an alarmin strongly produced
by neutrophils that stimulates osteoclast resorbing activity.
Conclusions: FcγRs play a crucial role in the development of bone erosion during AIA by inducing inflammation. In
particular, FcγRIV mediates bone erosion in AIA by inducing the influx of S100A8/A9-producing neutrophils into the
arthritic joint.
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Background
Rheumatoid arthritis (RA) is a chronic and systemic
autoimmune disease that primarily affects the joints [1].
Along with inflammation, excessive bone erosion is one
of the central hallmarks of this disease [2, 3]. Next to
generalized osteoporosis, severe focal bone erosions are
observed at the interface between the inflamed synovium
and the bone. Osteoclasts, which differentiate from mye-
loid precursor cells under the influence of macrophage
colony-stimulating factor (M-CSF) and receptor activa-
tor of nuclear factor-κB ligand (RANKL), are the cells
responsible for this deleterious process [4–6]. Therefore,
a deeper understanding of how the inflammatory re-
sponse increases bone erosion in this disease is likely to
be helpful in identifying new therapeutic targets.
Autoantibodies such as rheumatoid factor (RF) and
anticitrullinated protein antibodies are present in the
serum and synovial fluid of a large percentage of patients
with RA [1]. Of note, in patients with RA the presence of
autoantibodies predates disease onset and correlates with
disease progression and severity [7–9]. Immunoglobulin
G (IgG) antibodies can form immune complexes (ICs)
with their cognate antigens and subsequently bind to Fcγ
receptors (FcγRs), thereby modulating the activity of the
FcγR-bearing immune cells [10].
In mice, four different FcγRs have been identified, of
which the activating FcγRI, FcγRIII, and FcγRIV stimu-
late the cell via the activation motif immunoreceptor
tyrosine-based activation motif (ITAM), leading to
effector functions such as phagocytosis, antigen pres-
entation, and cytokine secretion. In contrast, FcγRIIb
is an inhibitory receptor, and its intracellular domain
contains an immunoreceptor tyrosine-based inhibitory
motif (ITIM) that counteracts the signaling of the acti-
vating FcγRs [10–12]. Alterations in the expression of
FcγRs have been described in circulating monocytes
and synovial tissue of patients with RA, suggesting
their involvement in the pathogenesis of RA [13–18].
Moreover, the crucial pathogenic role of FcγRs has
been proven in a multitude of experimental arthritis
models, such as collagen-induced arthritis (CIA),
glucose-6-phosphate isomerase-induced arthritis, col-
lagen type II antibody-induced arthritis, the K/B×N
serum transfer model, IC arthritis, and antigen-
induced arthritis (AIA) models. Overall, despite some
differences between the various experimental models,
activating FcγRs stimulate innate immune cells,
leading to deleterious effects. On the contrary, FcγRIIb
induces negative feedback in the production of auto-
antibodies, thereby protecting the joint from the devel-
opment and progression of the disease [19–28].
However, the function of the various FcγRs and their
exact mechanism of action in the modulation of bone
erosion remain to be elucidated.
In the AIA experimental RA model, the injection of
methylated bovine serum albumin (mBSA) into the knee
joints of previously immunized mice results in a strong
local accumulation of ICs that, via activation of the
immune system, are responsible for the degradation of
both bone and cartilage. In previous studies using this
model, we determined the relationship between synovial
inflammation and bone destruction using knockout
mouse strains for various (combinations of ) FcγRs. We
found that there was a link between FcγR-mediated in-
flammation and bone erosion [29]. Whereas FcγRs are
expressed on osteoclasts and may thus be involved in
their differentiation and activation, a central role in IC-
mediated inflammation has been attributed to the FcγR-
mediated activation of macrophages during AIA [30].
Their IC-mediated activation leads to the production of
a plethora of mediators, such as chemotactic factors, re-
sponsible for the recruitment of, among others, neutro-
phils into the joint. However, which FcγR is particularly
involved in regulating this cell influx and which cell is
dominant in mediating bone destruction is still a matter
of debate.
The importance of neutrophils in arthritis development
has been shown in the K/B×N serum transfer experimen-
tal RA model, in which depletion of neutrophils leads to
complete protection from disease development [31]. In
agreement with this finding, high numbers of neutrophils
are present in the joints of patients with active RA [32,
33]. Two factors produced by neutrophils in high quan-
tities are the alarmins S100A8 and S100A9, which make
up roughly 40% of all cytosolic proteins [34]. S100A8/A9
are small calcium-binding proteins that, upon cell stress,
are released into the extracellular environment, where
they function as potent inducers of the immune system
[35, 36]. High levels of S100A8/A9 are present in the syn-
ovial fluid of patients with RA [37, 38]. Moreover, it has
been shown that S100A8 is able to directly stimulate
osteoclast activity via TLR4, suggesting a possible mechan-
ism through which the IC-activated innate immunity can
regulate bone erosion in RA [39].
In the present work, we investigated the involvement of
FcγRs, and of FcγRIV in particular, in the regulation of
osteoclast-mediated bone resorption. We induced AIA in
mice deficient in all four FcγRs (FcγRI,II,III,IV−/− mice)
and in their wild-type (WT) controls. The role of FcγRIV
in particular was studied by comparing the development
of AIA in FcγRI,II,III,IV−/− and FcγRI,II,III−/−mice.
Methods
Animals
FcγRI,II,III,IV−/− mice in a C57BL/6 background were
developed by Dr. S. Verbeek (Leiden University Medical
Center, Leiden, the Netherlands) (Dr.J.Sjef Verbeek personal
communication, January 2016). Control C57BL/6 mice
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were purchased from Janvier Labs (Le Genest Saint Isle,
France). FcγRI,II,III−/− mice and their controls were
generated as previously described [29]. Mice were housed
under standard conditions in filter-top cages and fed a
standard diet with food and tap water ad libitum. All animal
studies were carried out according to the Dutch law and
approved by the local animal experimentation committee
(RU-DEC 2012-209).
Induction of AIA
Mice were immunized with 100 μg of mBSA (Sigma-Al-
drich, St. Louis, MO, USA) emulsified in complete
Freund’s adjuvant (CFA; Difco Laboratories, Detroit, MI,
USA). Heat-killed Bordetella pertussis was administrated
intraperitoneally as an additional adjuvant. One week
later, two subcutaneous injections in the neck region
with a total of 50 μg of mBSA/CFA were administered
as a booster. Three weeks after the immunization, arth-
ritis was induced in both knee joints by intra-articular
injection of 60 μg of mBSA in 6 μl of saline.
Serum collection and antibody titer determination in serum
At day 7 and day 21 after AIA induction, blood was
drawn from the retro-orbital plexus in MiniCollect tubes
(Greiner Bio-One, Monroe, NC, USA), and subsequently
serum was obtained by centrifugation. Anti-mBSA-
specific antibodies (total IgG, IgG1, IgG2a, IgG2b) were
measured in sera with an enzyme-linked immunosorbent
assay. mBSA was coated on plates (Nunc; Thermo Fisher
Scientific, Rochester, NY, USA) at a concentration of 100
μg/ml. Antibody concentrations were assessed by two-
fold serial dilution of the sera, followed by detection of
bound mouse IgG with peroxidase-conjugated rabbit
antimouse IgG (SouthernBiotech, Birmingham, AL, USA).
5-Aminosalicylic acid was used as a substrate. Absorbance
was measured at 450 nm. Antibody titers were determined
at 50% of the maximum absorption.
Lymphocyte stimulation test
Spleens were collected from mice at day 21 after AIA in-
duction and homogenized through a cell strainer. Eryth-
rocytes were lysed with lysis buffer (155 mM NH4Cl,
12 mM KHCO3, 0.1 mM ethylenediaminetetraacetic
acid, pH 7.3). Cells were seeded into flasks, and after
1 hour at 37 °C, nonadherent cells were harvested and
seeded into 96-well plates (1 × 105 cells/well). mBSA was
added at final concentrations of 50, 25, 12.5, 6.25, 3.12,
and 1.56 μg/ml. Concanavalin A and ovalbumin were used
as positive and negative controls, respectively. Cultures
were maintained for 4 days. [3H]Thymidine was added for
the last 16 hours of culture, and its incorporation was
determined as a measure of T-cell proliferation.
Histological analysis
Total knee joints were isolated, fixed in 4% phosphate-
buffered formalin, decalcified in 5% formic acid, embedded
in paraffin, and 7-μm coronal sections of various depths of
the joint were made. Sections were stained with H&E for
histological analysis. Inflammation (infiltrate and exudate)
was arbitrarily scored on a scale from 0 (no inflammation)
to 3 (severe inflammation). Bone destruction was evaluated
in 13 well-defined areas of the knee joint (as depicted in the
scheme in Additional file 1a) with a score ranging from 0
(no erosion) to 3 (connection between joint cavity and bone
marrow). For the evaluation of proteoglycan (PG) depletion
as a measure of cartilage destruction, joint sections were
stained with Safranin O and Fast Green. PG depletion was
evaluated at both the patellofemoral and the tibiofemoral
areas as the amount of red staining present, using an arbi-
trary score ranging from 0 (absence of PG depletion) to 3
(complete PG depletion). For quantification of the number
of osteoclasts, total knee joint sections were stained for
tartrate-resistant acid phosphatase (TRAP), using the
Leukocyte Acid Phosphatase Kit (Sigma-Aldrich) according
to the manufacturer’s protocol. The number of TRAP+ cells
present along the external bone surface was counted. For
quantification of periarticular bone, the percentage of
noncartilage collagenous tissue (blue staining) in the
complete femur and tibia of joint sections stained with
Safranin O and Fast Green was quantified using Leica
Application Suite software (Leica Microsystems, Buffalo
Grove, IL, USA).
Immunohistochemistry
To visualize S100A8-, NIMPR14-, and F4/80-expressing
cells, knee joint sections were incubated with specific pri-
mary antibodies against S100A8 (made in our facilities),
NIMPR14 (kindly provided by Dr. M. Strath, London, UK)
and F4/80 (Thermo Fisher Scientific). Afterward, sections
were incubated with horseradish peroxidase-conjugated or
biotinylated secondary antibodies followed by avidin-biotin
complex peroxidase (VECTASTAIN Elite Kit; Vector La-
boratories, Burlingame, CA, USA). Antibody binding was vi-
sualized using diaminobenzidine. S100A8 staining was
arbitrarily scored using a scale from 0 to 3. For quantifica-
tion of NIMPR14- and F4/80-positive cells, pictures (original
magnification ×100) of five specific areas of the joint were
taken (two in the area adjacent to the patella and two in the
area adjacent to the medial and lateral femur for the evalu-
ation of infiltrate, and one in the area of the joint cavity be-
tween the patella and femur for evaluation of the exudate).
The amount of cells in the infiltrate was measured as the
positive area above a fixed threshold using Leica Application
Suite software (Leica Microsystems). The number of positive
cells in the exudate was counted using the cell counter plu-
gin of ImageJ software (National Institutes of Health, Be-
thesda, MD, USA).
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Flow cytometric analysis
Bone marrow was isolated from femurs and tibias of
mice by flushing the marrow cavity with medium and
passing the cell suspension through a cell strainer. After
lysis of erythrocytes, bone marrow cells were incubated
with Fc-blocking antibody (BD Pharmingen antimouse
CD16/CD32, clone 2.4G2; BD Biosciences, San Jose, CA,
USA), followed by staining with the following mix of
antibodies: CD11b-fluorescein isothiocyanate, CD90.2-
phycoerythrin (PE), CD45R/B220-PE, CD49b-PE, NK1.1-
PE, Ly6G-PE, Ly6C-allophycocyanin-cyanine 7 (all BD
Biosciences). Samples were acquired with a CyAn flow
cytometer (Beckman Coulter Life Sciences, Indianapolis,
IN, USA), and data analysis was performed with Kaluza
Analysis Software (Beckman Coulter Life Sciences). The
gating strategy we used is depicted in Additional file 2.
Bone marrow-derived osteoclast differentiation
Bone marrow was isolated from femurs and tibias of mice.
Total bone marrow cells were seeded into 96-well plates
at a density of 105 cells/well in 150 μl of α-minimum es-
sential medium (Thermo Fisher Scientific), supplemented
with 5% FCS, penicillin/streptomycin, 30 ng/ml recombin-
ant mouse (rm)M-CSF, and 20 ng/ml rmRANKL (R&D
Systems, Minneapolis, MN, USA). Culture medium was
refreshed after 3 days.
Measurement of TRAP activity in the supernatants
Cell supernatants were collected after 5 days of differen-
tiation, and TRAP activity was measured with a colori-
metric assay. In short, p-nitrophenyl phosphate (New
England Biolabs, Ipswich, MA, USA) was diluted in buf-
fer containing 420 mM acetic acid (Sigma-Aldrich) and
160 mM tartrate solution (Merck, Kenilworth, NJ, USA)
and added 1:1 to culture supernatant. After 1 hour, the
reaction was stopped with 0.5 M NaOH (Sigma-Aldrich)
, and the absorbance at 405 nm was determined using a
spectrophotometric plate reader (Bio-Rad Laboratories,
Hercules, CA, USA).
RNA isolation and qRT-PCR
Well-defined synovial samples were isolated from the in-
flamed murine knee joints as previously described [40]. Tis-
sue samples were homogenized using the MagNA Lyser
Instrument (Roche Diagnostics, Indianapolis, IN, USA). Total
RNA was isolated using the RNeasy Fibrous Tissue Mini Kit
(Qiagen, Hilden, Germany). RNA from osteoclast cultures
was isolated with TRIzol reagent (Sigma-Aldrich). RNA was
subsequently reverse-transcribed into complementary DNA.
qRT-PCR was performed using the Applied Biosystems
StepOnePlus RT-PCR System (Thermo Fisher Scientific,
Foster City, CA, USA). Primer sequences are listed in Table 1
(primers obtained from Biolegio, Nijmegen, the Netherlands).
Glyceraldehyde 3-phosphate dehydrogenase (Gapdh) was
used as the reference gene. Samples were normalized for the
expression of Gapdh by calculating the comparative thresh-
old: −ΔCt = − (Ct gene of interest − Ct Gapdh).
Statistical analysis
Statistical differences between two groups were calculated
using Student’s t test for parametric variables (messenger
RNA [mRNA] expression, IgG titer) or the Mann-
Whitney U test for nonparametric variables (lymphocyte
stimulation test/arbitrary score of inflammation, PG de-
pletion, and S100A8 staining/percentage of osteoclast pre-
cursors/number of TRAP-positive cells in vivo/TRAP
activity in the supernatant/quantification of NIMPR14-
and F4/80-positive cells/percentage of noncartilage calci-
fied tissue). For comparison of multiple groups in the
quantification of in vivo bone erosion and TRAP+ cells
after in vitro differentiation, two-way analysis of variance
was used. Spearman’s rank correlation coefficients (rS)
were calculated for correlation analysis. All analyses were
performed using Prism version 5.03 software (GraphPad
Software, La Jolla, CA, USA), and P values less than 0.05
were considered significant.
Results
Decreased bone erosion in FcγRI,II,III,IV−/− mice compared
with WT controls
First, to determine the effect of the absence of FcγRs on
bone resorption during experimental arthritis, we scored
bone erosion after induction of AIA in FcγRI,II,III,IV−/−
mice and their WTcontrols. At both day 7 and day 21 after
AIA induction, we observed significantly decreased bone
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erosion in the FcγRI,II,III,IV−/− mice as compared with
their WT controls, highlighting the importance of FcγRs in
this process (Fig. 1). However, although the bone erosion
was significantly decreased in the FcγRI,II,III,IV−/− mice
compared with their WT controls, scores were not reduced
to the same level of in naive mice. To investigate a possible
basal phenotype due to the absence of FcγRs, we determined
the bone erosion in knee joints of WT and FcγRI,II,III,IV−/−
mice without AIA. This showed comparable basal levels of
bone erosion in these naive knee joints (Fig. 1b). In addition,
no differences were found in the surface area of
noncartilage collagenous tissue present in the femur and
tibia (Additional file 1b). Together, these findings suggest
that the decreased bone resorption that was observed in
the FcγRI,II,III,IV−/− mice after induction of experimental
arthritis could not be explained by an underlying basal
bone phenotype. As an additional readout of joint
damage, we evaluated PG depletion as a measure of
inflammation-induced cartilage destruction at the patello-
femoral and tibiofemoral regions. In line with the
decreased bone damage, we observed decreased PG deple-
tion in FcγRI,II,III,IV−/− mice compared with their WT
controls at day 7 and day 21 after AIA induction,
particularly in the tibiofemoral area (Additional file 1c).
Fig. 1 Fcγ receptor (FcγR)I,II,III,IV−/− mice have decreased bone erosion compared with wild-type (WT) control mice. a Bone erosion (black arrows)
is present in the joints of FcγRI,II,III,IV−/− and WT mice after induction of antigen-induced arthritis (AIA), as determined by using H&E-stained sections.
Original magnification ×50 and ×200. b Quantification of bone erosion showed significantly decreased resorption in the joints of FcγRI,II,III,IV−/− mice
compared with their WT controls (n = 17 and 24 joints per group respectively) at both 7 and 21 days after AIA induction. No basal differences in bone
erosion could be observed in the joints of naive mice. Scatterplots are shown, with horizontal and vertical lines representing mean ± SEM
values. ns Not significant. ** P < 0.01, *** P < 0.001 versus WT controls
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Comparable immune response against mBSA in WT and
FcγRI,II,III,IV−/− mice
Because the induction of the AIA model is highly
dependent on the immune response against the mBSA
antigen, we set out to determine whether the humoral
and cellular immune responses against mBSA were
affected by the absence of FcγRI,II,III,IV. Therefore, we
determined anti-mBSA IgG titers in the serum of mice
with AIA. We found increased titers of total IgG, IgG1,
and IgG2a, but a comparable titer of IgG2b, in
FcγRI,II,III,IV−/− mice as compared with WT mice (Fig. 2a).
Moreover, using immunostaining against IgG in the joint,
we showed IgG accumulation in both WT and
FcγRI,II,III,IV−/− mice (Fig. 2b). Finally, we observed
comparable mBSA-induced proliferation of T cells obtained
from FcγRI,II,III,IV−/− and WT mice (Fig. 2c).
Absence of Fcγ receptors does not affect the number of
osteoclast precursors
In the next set of experiments, we aimed at elucidating
the mechanism underlying the decreased bone erosion ob-
served in the absence of FcγRs. We first determined
whether the FcγRI,II,III,IV−/− mice had a different
percentage of osteoclast precursors in their bone marrow
after induction of AIA. The percentage of CD11bposLy6Chigh
and CD11blow/negLy6Chigh cells, both of which have been
shown to differentiate into osteoclasts [41, 42], were
comparable between FcγRI,II,III,IV−/− and WT mice (Fig. 3a).
These data suggest that the observed decrease in bone
erosion does not originate from differences in osteoclast
precursor populations.
Absence of Fcγ receptors does not affect the
osteoclastogenic potential and the number of
osteoclasts on the bone surface during AIA
Next, we determined whether the osteoclast progenitors
from FcγRI,II,III,IV−/− mice have the same osteoclastogenic
potential as WT cells. After in vitro differentiation of bone
marrow cells into osteoclasts with M-CSF and RANKL, we
Fig. 2 Fcγ receptor (FcγR)I,II,III,IV deficiency does not impair the
humoral and cellular immune responses against methylated bovine
serum albumin (mBSA). a Significantly increased anti-mBSA total
immunoglobulin G (IgG), IgG1, and Ig2a titers were measured in the
serum of FcγRI,II,III,IV−/− mice compared with those of wild-type (WT)
mice, whereas IgG2b titers were not significantly different (WT,
n = 14; FcγRI,II,III,IV−/−, n = 10; combined from day 7 and day 21). b
Accumulation of IgG was present in the knee joints of both WT and
FcγRI,II,III,IV−/− mice 7 days after induction of antigen-induced arthritis
as determined by immunolocalization. Original magnification ×400. c
The cellular anti-mBSA immune response, as determined by T-cell
proliferation, was comparable between WT and FcγRI,II,III,IV−/− mice.
Results are expressed as stimulation index (ratio of stimulation with/
without antigen) (n = 4 mice/group). Scatterplots are shown, with
horizontal and vertical lines representing mean ± SEM values. ns Not
significant. * P < 0.05, ** P < 0.01, *** P < 0.001
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observed comparable numbers of multinucleated TRAP+
cells in the cultures with WT and FcγRI,II,III,IV−/− cells
(Fig. 3b). In agreement with this finding, we found
comparable mRNA expression levels of key osteoclast
differentiation markers, such as nuclear factor of activated
T-cells, cytoplasmic 1 (Nfatc1),TRAP, dendritic cell-specific
transmembrane protein (Dcstamp), calcitonin receptor
(Ctr), and osteoclast-associated immunoglobulin-like recep-
tor (Oscar), as well as comparable mRNA expression levels
of activation markers, such as chloride channel 7 (Clcn7),
Fig. 3 Absence of Fcγ receptor (FcγR)I,II,III,IV does not affect the percentage of osteoclast precursors and their osteoclastogenic potential. a Comparable
percentages of CD11bposLy6Chigh and CD11blow/negLy6Chigh osteoclast precursors were present in the bone marrow of wild-type (WT) and FcγRI,II,III,IV−/−
mice at days 7 and 21 of antigen-induced arthritis (AIA) (n= 3 or 4 mice/group). b Images of tartrate-resistant acid phosphatase (TRAP) staining of osteo-
clasts after 5 days of in vitro differentiation. Quantification showed comparable numbers of osteoclasts obtained from WT and FcγRI,II,III,IV−/− bone marrow
cells (n= 5 mice/group). c Moreover, comparable messenger RNA expression levels of various osteoclast markers were determined in WT and FcγRI,II,III,IV−/
− osteoclasts (n= 3 mice/group). d Finally, TRAP activity in the culture supernatant of WT and FcγR I,II,III,IV−/− macrophages and osteoclasts was comparable
(n= 3 mice/group). e Representative photomicrographs of TRAP staining and quantification of the number of positive cells along the bone surface in total
knee joint sections of WT and FcγRI,II,III,IV−/− mice at days 7 and 21 after induction of AIA (n= 14 and n= 10 per time point for WT and FcγRI,II,III,IV−/− mice,
respectively). Scatterplots are shown, with horizontal and vertical lines representing mean ± SEM values. ns Not significant
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carbonic anhydrase II (Ca2), matrix metallopeptidase 9
(Mmp9), and cathepsin K (Ctsk) (Fig. 3c). Moreover, the
TRAP enzyme activity as measured in the supernatant of
the osteoclast cultures was comparable (Fig. 3d). Together,
these findings show that the absence of FcγRs does not
affect the osteoclastogenic potential of precursor cells.
Finally, because in vivo osteoclastogenesis is a complex
process that can be influenced by many factors, we deter-
mined the number of osteoclasts on the bone surface of
FcγRI,II,III,IV−/− and WT mice during AIA using TRAP
staining. Interestingly, in line with their comparable
osteoclastogenic potential in vitro, the number of TRAP+
cells along the bone surface did not differ between
FcγRI,II,III,IV−/− and WT mice both at day 7 and day 21
after AIA induction (Fig. 3e).
FcγRs differentially regulate the influx of neutrophils
present in the joint
Because proinflammatory cells and their products can
strongly increase the resorbing activity of osteoclasts, we
evaluated the severity of inflammation in the arthritic knee
joints. The degree of both infiltrate and exudate was sig-
nificantly decreased in the knee joints of FcγRI,II,III,IV−/−
mice at day 7 after AIA induction (Fig. 4). At day 21 after
induction, the degree of inflammation was decreased in
both strains, and no significant difference could be
observed between FcγRI,II,III,IV−/− and WT mice
anymore. The early phase of inflammation (day 7) during
AIA is particularly characterized by an abundant presence
of neutrophils in the exudate and infiltrate in the knee
joint. Interestingly, we observed significantly decreased
numbers of NIMPR14-positive neutrophils in the exudate,
and the NIMPR14-positive area in the infiltrate was sig-
nificantly lower in FcγRI,II,III,IV−/− mice than in WT
mice (Fig. 5a). In contrast, numbers of F4/80-positive
monocytes/macrophages in both the exudate and infiltrate
were comparable between FcγRI,II,III,IV−/− and WT mice
(Fig. 5b), and a trend toward an increased percentage of
F4/80 cells in the infiltrate of FcγRI,II,III,IV−/− mice was
observed. Previous data developed at our laboratory
showed that in contrast to the decreased inflammation
and bone resorption in FcγRI,II,III,IV−/− mice that we
describe in the present work, FcγRI,II,III−/− mice showed
increased bone resorption, together with more
inflammation, compared with their WT controls after
induction of AIA [29]. Of note, we observed a significant
increase and a trend toward an increase in the numbers of
neutrophils present in the infiltrate and exudate,
respectively, of these FcγRI,II,III−/− mice (Fig. 5c). However,
in agreement with our findings in the FcγRI,II,III,IV−/−
mice, the number of F4/80-positive monocytes/
macrophages cells was not significantly different between
FcγRI,II,III−/− and WT mice, and the percentage of F4/80-
positive area was decreased in FcγRI,II,III−/− mice
(Fig. 5d). Representative photomicrographs are shown
in Additional files 3 and 4. Together, these findings
suggest that FcγRIV might be of particular
importance in the recruitment of neutrophils into the
arthritic joint and that these neutrophils likely
contribute to the bone erosion process.
Numbers of S100A8/A9-producing neutrophils strongly
correlate with the amount of bone erosion
In line with the decreased numbers of neutrophils present
in their joints, lower expression levels of S100A8, at both
the mRNA and protein levels, were observed in
FcγRI,II,III,IV−/− than in WT mice (Fig. 6a and b).
Moreover, in agreement with the higher numbers of
neutrophils observed in the joints of FcγRI,II,III−/− mice,
increased expression of S100A8 was previously described
by researchers at our laboratory [24]. Supporting our idea
that the S100A8 produced by neutrophils plays an
important role in the observed bone erosion, we found
that the number of neutrophils in both the infiltrate and
exudate, as well as their production of S100A8, strongly
and significantly correlated with the severity of bone
erosion (Fig. 6c and d).
Discussion
In the present study, we show that FcγRs are crucially
involved in bone erosion during AIA. Moreover, we
show that the absence of all FcγRs does not affect the
number of osteoclast precursors or their osteoclasto-
genic potential, but that it decreases the subsequent
bone erosion during experimental arthritis via a reduc-
tion of inflammation. The comparison of development
of AIA in FcγRI,II,III,IV−/− and FcγRI,II,III−/− mice
suggested a possible crucial role of FcγRIV in mediating
neutrophil inflammation during AIA.
We observed that mice lacking all FcγRs had decreased
inflammation at day 7 and decreased bone erosion at both
day 7 and day 21 after induction of the disease. This is in
agreement with a previous study by Hobday and col-
leagues, which showed that FcγRI,II,III,IV−/− mice were
completely protected from serum-transferred arthritis at a
macroscopic level [43]. However, in contrast to this serum
transfer model, the AIA model is characterized by clear T-
cell involvement, which is probably FcγR-independent.
This might explain why we did not observe complete
protection in FcγRI,II,III,IV−/− mice. In another study, in
line with what we observed in FcyRI,II,III,IV-/- mice, y-
chain/FcyRIIb -/- mice lacking signaling of both activating
and inhibitory FcγRs, as well as of other receptors using
the γ-chain, were completely protected from development
of CIA, although bone erosion data were not reported [44].
The induction of the AIA experimental RA model
is highly dependent on the binding of mBSA/anti-
mBSA-containing ICs to FcγRs, thereby potently
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activating the cell, and on the activation of T-cell re-
sponses against mBSA. However, we observed com-
parable T-cell responses against the mBSA antigen in
FcγRI,II,III,IV−/− and WT animals, which shows that
their contribution to the induction of the model was
not affected by the absence of the FcγRs. This is
consistent with previous studies in which normal T-
cell responses were found in the absence of either ac-
tivating or inhibitory FcγRs after the induction of the
AIA [27, 28]. Together, these findings suggest that
the development of the T-cell immune response is
FcγR-independent.
It has previously been shown that the absence of
FcγRIIb often leads to increased IgG titers in mice owing
to a lack of negative feedback on the production of IgGs
by plasma cells, which results in enhanced stimulation
of the immune response [28, 45]. In line with these find-
ings, the FcγRI,II,III,IV−/− mice used in this study, which
also lack FcγRIIb, showed increased IgG titers (total IgG,
IgG1, IgG2a) compared with their WT controls.
Moreover, accumulation of IgG was present in the joints
of FcγRI,II,III,IV−/− mice. Together, these data showing a
normal T-cell response against mBSA and increased IgG
titers in FcγRI,II,III,IV−/− mice suggest that the observed
decrease in bone pathology cannot be the result of an
insufficient immune response against mBSA after
induction of the AIA model.
Osteoclasts are the main cells responsible for the deg-
radation of bone tissue during RA. Although it is known
that osteoclasts differentiate from bone marrow-derived
myeloid precursors under the influence of M-CSF and
RANKL, a strictly defined osteoclast precursor set has
not yet been identified [4]. CD11bposLy6Chigh bone
marrow monocytes have been reported to differentiate
into osteoclasts when stimulated with M-CSF and
RANKL in vitro, and depletion of Ly6Chigh cells in vivo
results in decreased osteoclast formation and
subsequent bone resorption in the K/B×N serum
transfer model [41]. Moreover, Charles and colleagues
recently identified the CD11blow/negLy6Chi bone
marrow population as having osteoclastogenic potential
both in vitro and in vivo [42]. In the present study, we
did not observe differences in the relative percentages of
both the Ly6Chigh and CD11blow/negLy6Chigh osteoclast
precursor populations between FcγRI,II,III,IV−/− and WT
mice, which allowed us to exclude the possibility that
decreased bone erosion in the FcγRI,II,III,IV−/− mice was
merely the result of decreased numbers of osteoclast
precursors.
Next to M-CSF and RANKL signaling, a costimulatory
signal via the activation of the ITAM domain, which is
present in the γ-chain and in DNAX activation protein
of 12 kDa (DAP-12), is required for the activation of
NFATc1, which is the transcription factor essential for
osteoclast differentiation [46, 47]. Because activating
FcγRI, FcγRIII, and FcγRIV are expressed by osteoclasts
and are associated with the ITAM-containing γ-chain,
they potentially can affect osteoclast differentiation.
However, in the present study, we found that the ab-
sence of all four FcγRs does not impact the differenti-
ation of osteoclasts from their precursors in vitro.
Underlining our findings, Negishi-Koga and colleagues
Fig. 4 Fcγ receptor (FcγR)I,II,III,IV−/− mice have decreased inflammation in arthritic joints. Photomicrographs of H&E staining showing the infiltrate
and exudate in knee joints of wild-type (WT) and FcγRI,II,III,IV−/− mice at days 7 and 21 of antigen-induced arthritis (AIA). Original magnification
×100. Quantification showed decreased infiltrate and exudate in the knee joints of FcγRI,II,III,IV−/− mice compared with WT controls at day 7 of
AIA. In contrast, no differences were observed at day 21 (n = 24 and n = 17 joints per time point for WT and FcγRI,II,III,IV−/− mice, respectively).
Scatterplots are shown, with horizontal and vertical lines representing mean ± SEM values. ns Not significant. * P < 0.05, ** P < 0.01
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showed that FcγRIIb−/−/γ-chain−/− cells, which lack
signaling of both activating and inhibitory FcγRs, did not
show alterations in osteoclast differentiation. However,
varying results have previously been described
concerning the effects of FcγRs on osteoclastogenesis.
Surprisingly, Negishi-Koga and colleagues reported that
FcγRIII−/− mice have an osteoporotic phenotype that
was associated with increased numbers of osteoclasts.
These authors also demonstrated increased in vitro
osteoclast differentiation of FcγRIII−/− bone marrow
cells, together suggesting an inhibitory role for FcγRIII
in osteoclastogenesis [48]. They stated that the mechanistic
Fig. 5 Prominent role for Fcγ receptor (FcγR)IV in regulating the influx of neutrophils into the joint. a NIMPR14-positive area, percentage of NIMPR14-
positive area in the infiltrate, and number of NIMPR14-positive cells in the exudate are decreased in FcγRI,II,III,IV−/− mice compared with wild-type (WT)
mice in day 7 antigen-induced arthritis (AIA). b Comparable numbers of F4/80-positive cells are present in the joints of FcγRI,II,III,IV−/− mice compared
with their WT controls at day 7 AIA. c In contrast to FcγRI,II,III,IV−/− mice, the total NIMPR14-positive area, percentage of NIMPR14-positive area in the
infiltrate, and number of NIMPR14-positive cells in the exudate are increased in FcγR I,II,III−/− mice. d Comparable numbers and reduced percentage
of F4/80-positive cells in the joint of FcγR I,II,III−/− mice compared with their WT controls at day 7 of AIA. Scatterplots are shown, with horizontal and
vertical lines representing mean ± SEM values of at least six mice per group. ns Not significant. * P < 0.05, ** P < 0.01
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Fig. 6 (See legend on next page.)
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basis for this surprising finding could be the sequestration
of the γ-chain by FcγRIII. Therefore, in the absence of
FcγRIII, more γ-chain is available for other proteins, such
as osteoclast-associated immunoglobulin-like receptor
(OSCAR) and paired immunoglobulin-like receptor A
(PIR-A), which both act as costimulatory factors during os-
teoclastogenesis via their association with the γ-chain. In
addition, the same research group showed that FcγRIIb−/−
cells, which lack the ITIM domain that inhibits pro-
osteoclastogenic ITAM signaling, showed increased
osteoclastogenic potential. Therefore, in the present study,
where we show that FcγRI,II,III,IV−/− cells have normal
in vitro osteoclastogenic potential, we cannot rule out a
compensatory effect on osteoclast differentiation via γ-
chain-dependent costimulatory pathways, such as via
OSCAR or PIR-A signaling, or via triggering receptor
expressed on myeloid cells 2 (TREM2), which depends on
the ITAM-domain containing DAP12 protein for its signal-
ing. In line with this possibility, it has been shown that
DAP12 is primarily responsible for in vitro M-CSF- and
RANKL-induced osteoclastogenesis because γ-chain−/−
cells show normal differentiation. However, in the absence
of DAP12, the γ-chain can compensate for its absence, act-
ing via αvβ3 integrin [49].
Finally, underlining the normal osteoclast differentiation
that we observed in vitro, nonarthritic FcγRI,II,III,IV−/−
mice had no basal bone phenotype in their knee joints,
measured as the amount of subchondral calcified tissue in
the femur and tibia, and we observed comparable
numbers of TRAP+ osteoclasts along the bone surface
after AIA induction. Together, these findings imply that
the absence of all FcγRs does not impair the ability of cells
to differentiate into mature osteoclasts, suggesting that a
difference in osteoclast activity, rather than differences in
osteoclast numbers, must underlie the decreased erosion
in FcγRI,II,III,IV−/− mice in the studied AIA model.
It has been shown that inflammation plays a critical role
in the activation of osteoclasts in vivo by the production
of a plethora of factors that in this way lead to bone ero-
sion. In this study, we found that inflammation (both infil-
trate and exudate) was decreased in FcγRI,II,III,IV−/− mice
compared with WT controls at day 7, but not at day 21,
after AIA induction. This suggests that FcγRs are probably
most involved in the early inflammatory response of the
AIA model, which still resulted in significantly decreased
bone erosion in the FcγRI,II,III,IV−/− mice at day 21
after induction.
It has been shown that the four FcγRs in mice are differ-
entially expressed on immune cells and that the individual
FcγRs are known to bind the various IgG subclasses with
different affinities [10]. The activity of IgG1 is dependent
mainly on FcγRIII, and IgG2a binds with high affinity to
FcγRI and with low affinity to FcγRIII and IV, whereas
IgG2b bind with the highest affinity to FcγRIV. This im-
plies that the absence of one or more FcγRs and the cellu-
lar composition might facilitate the binding of IgGs to
other FcγRs more than normally would occur, possibly
leading to abnormal intracellular signaling. Previous re-
searchers have investigated the role of FcγRs in AIA using
mice deficient in one or more FcγRs. Induction of AIA in
FcγRIIb−/− mice resulted in increased inflammation, most
probably because of the absence of both FcγRIIb-
mediated IgG clearance and a negative feedback loop on
IgG production by B cells [28, 29]. In contrast, the
inflammation in FcγRI−/− or FcγRIII−/− mice was not
affected [28], suggesting that either these receptors can
compensate for each other’s absence or that FcγRIV is the
dominant FcγR in both cases. However, the combined
absence of FcγRI and FcγRIII [24] led to reduced
inflammation. Interestingly, when combined with the
absence of the IgG-clearing FcγRIIb, resulting in
FcγRI,II,III−/− mice, stronger accumulation of ICs is
present, which results in increased inflammation, probably
via binding of ICs to FcγRIV [29]. The important function
of FcγRIV in this situation is substantiated by the finding
that the inflammation is reduced when, in addition to
FcγRI, FcγRII, and FcγRIII, FcγRIV is also absent.
Although our results indicate an important role for FcγRIV
in the pathology of AIA, definitive proof should come from
AIA induction in an FcγRIV single-knockout. Consistent
with our findings in the AIA model, the fact that 35–40%
of FcγRI,II,III−/− mice developed CIA, whereas γ-chain−/
−/FcγRIIb−/−mice that also lack functional FcγRIV were
protected from disease development, further supports the
role of FcγRIV in this arthritis model [44]. Moreover, a
clear confirmation for the crucial involvement of
(See figure on previous page.)
Fig. 6 The number of S100A8-producing neutrophils correlates with the severity of bone erosion during antigen-induced arthritis. a S100a8 messenger
RNA levels in the synovium of Fcγ receptor (FcγR)I,II,III,IV−/− mice are decreased compared with wild-type (WT) mice at day 7 of antigen-
induced arthritis (AIA). b Representative photomicrographs show S100A8 staining in knee joint sections of WT and FcγRI,II,III,IV−/− mice at
day 7 of AIA. Original magnification ×100 and ×400. Quantification showed a decreased number of S100A8-positive cells in FcγRI,II,III,IV−/−
mice compared with their WT controls. c A significant correlation was observed between the number of neutrophils (NIMPR14-positive
cells) in the infiltrate and exudate in the joint and bone erosion in both WT and FcγRI,II,III,IV−/− mice at day 7 of AIA. d A significant
correlation between the number of S100A8-positive cells in the joint and the severity of bone erosion in both WT and FcγRI,II,III,IV −/− mice
at day 7 of AIA was found. * P < 0.05. rs = Spearman’s rank correlation coefficient
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FcγRIV in K/B×N comes from a study by Seeling and
colleagues in which FcγRIV−/− animals showed
significantly decreased inflammation and bone erosion
[41]. Finally, arthritis development can be prevented
using a blocking antibody against FcγRIV in mice
lacking all FcγRs except for FcγRIV [50].
Together, these studies and the data reported in the
present article show that an important role can likely be
attributed to FcγRIV in experimental RA models. Inter-
estingly, a polymorphism in FcγRIIIA, which is the hu-
man ortholog of the murine FcγRIV, has been associated
with increased susceptibility to RA development. This
polymorphism, in which a phenylalanine is substituted
for a valine at amino acid position 158 (158 V/F), located
at the immunoglobulin-binding domain, results in an in-
creased affinity of the receptor for IgG1 and IgG3 anti-
bodies [51–53]. Although these associations could not
be reproduced in all populations, these data support a
possible important role for the human ortholog of mur-
ine FcγRIV in RA development and further support the
importance of additional studies to investigate the role
of FcγRs in RA [54].
In our present study, we describe a clear increase in the
numbers of neutrophils in both the infiltrate and exudate
in FcγRI,II,III−/− mice, whereas decreased neutrophil
numbers were observed in FcγRI,II,III,IV−/− mice. This
suggests that particularly FcγRIV is responsible for the
presence of neutrophils to the joint. The importance of
neutrophils in RA development has been shown in the K/
B×N experimental RA model [31]. Moreover, in
agreement with this role for neutrophils in experimental
RA models, high numbers of neutrophils are present in
the joints of patients with active RA [32, 33]. We show a
strong and significant correlation between the number of
neutrophils present in the joint and the amount of bone
erosion. Because in the AIA model ICs are produced locally
in the joint, we propose that ICs can stimulate synovial
macrophages via FcγRIV to release chemotactic factors
such as complement components and keratinocyte-derived
chemochine, thereby inducing the recruitment of neutro-
phils into the joint. Neutrophils are strong producers of the
alarmin S100A8/A9, which has been shown to directly in-
duce osteoclast activity in vitro via TLR4 signaling [39].
This suggests a mechanism through which infiltrated neu-
trophils can regulate bone erosion in RA. Indeed, we ob-
served lower expression levels of S100A8 coinciding with
lower neutrophil numbers in the joints of FcγRI,II,III,IV−/−
mice than in WT mice. Moreover, we observed that the
production of S100A8 by neutrophils strongly and
significantly correlated with the severity of bone erosion. In
agreement with these findings, our laboratory previously
showed that FcγRI,II,III−/− mice, which have increased
numbers of neutrophils in their joints after AIA induction,
showed increased S100A8 expression. S100A8/A9 has been
shown to be strongly upregulated in the synovial fluid of
patients with RA [37, 38], and its levels are linked to joint
inflammation and damage [55–58]. Together, these data
support the idea that FcγRIV mediates bone erosion in AIA
by modulating the influx of S100A8/A9-producing
neutrophils into the arthritic joint, although an additional
direct effect of ICs on osteoclasts cannot be completely
ruled out.
Conclusions
Our present study adds important new data to the existing
body of knowledge concerning the involvement of FcγRs
in inducing bone erosion and particularly highlights, for
the first time to our knowledge, the role of FcγRIV in
neutrophil-mediated bone erosion during AIA.
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